Clinical Trial
doi: 10.1017/s0022215100109958.
Nasal decongestant effect of oxymetazoline in the common cold: an objective dose-response study in 106 patients
Affiliations
- PMID: 2671220
- DOI: 10.1017/s0022215100109958
Item in Clipboard
Clinical Trial
Nasal decongestant effect of oxymetazoline in the common cold: an objective dose-response study in 106 patients
J Laryngol Otol.
1989 Aug.
Abstract
Oxymetazoline has been used as decongesting nosedrops for more than 25 years but so far no objective dose-response study of the drug has been published. In this double-blind clinical trial the decongestant effect on the nasal mucosa by the doses and concentrations traditionally used of oxymetazoline were studied. In 106 men with acute infectious rhinitis, a significant dose-response relationship was found when the decongestant effect was measured objectively by anterior rhinomanometry and subjectively by symptom scores. The concentration and volumes of the drug recommended from clinical experience seem to be adequate.
Similar articles
-
The effect of topical decongestant on blood flow in normal and infected nasal mucosa.Acta Otolaryngol. 1983 Nov-Dec;96(5-6):523-7. doi: 10.3109/00016488309132740. Acta Otolaryngol. 1983. PMID: 6637461
-
[Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis].HNO. 2003 Oct;51(10):794-9. doi: 10.1007/s00106-003-0869-z. HNO. 2003. PMID: 14523532 Clinical Trial. German.
-
Oxymetazoline in the treatment of allergic and non-infectious conjunctivitis.J Int Med Res. 1979;7(6):528-30. doi: 10.1177/030006057900700609. J Int Med Res. 1979. PMID: 391626 Clinical Trial.
-
The nasal decongestant effect of xylometazoline in the common cold.Am J Rhinol. 2008 Sep-Oct;22(5):491-6. doi: 10.2500/ajr.2008.22.3202. Epub 2008 Jul 24. Am J Rhinol. 2008. PMID: 18655753 Clinical Trial.
-
Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold.Curr Med Res Opin. 2010 Apr;26(4):889-99. doi: 10.1185/03007991003648015. Curr Med Res Opin. 2010. PMID: 20151787 Review.
Cited by
-
Epidemiology, pathogenesis, and treatment of the common cold.Ann Allergy Asthma Immunol. 1997 Jun;78(6):531-9; quiz 539-40. doi: 10.1016/S1081-1206(10)63213-9. Ann Allergy Asthma Immunol. 1997. PMID: 9207716 Free PMC article. Review.
-
Treatment of the common cold.BMJ. 1998 Jul 4;317(7150):33-6. doi: 10.1136/bmj.317.7150.33. BMJ. 1998. PMID: 9651268 Free PMC article. Review. No abstract available.
-
Dexpanthenol: An Overview of its Contribution to Symptom Relief in Acute Rhinitis Treated with Decongestant Nasal Sprays.Adv Ther. 2017 Aug;34(8):1850-1858. doi: 10.1007/s12325-017-0581-0. Epub 2017 Jul 10. Adv Ther. 2017. PMID: 28695477 Free PMC article. Clinical Trial.
-
Objective monitoring of nasal patency and nasal physiology in rhinitis.J Allergy Clin Immunol. 2005 Mar;115(3 Suppl 1):S442-59. doi: 10.1016/j.jaci.2004.12.015. J Allergy Clin Immunol. 2005. PMID: 15746882 Free PMC article. Review.
-
Nasal decongestants in monotherapy for the common cold.Cochrane Database Syst Rev. 2016 Oct 17;10(10):CD009612. doi: 10.1002/14651858.CD009612.pub2. Cochrane Database Syst Rev. 2016. PMID: 27748955 Free PMC article.